EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Deuterium‐Oxide Labelling Proteomics Illustrates the Importance of Sample Timing and the Limitations of Serial Biopsies

Colleen L O'Reilly iD, Michael E Taylor iD, Kamil A Kobak, Ying Ann Chiao iD, Rovshan G Sadygov iD, Michael T Kinter, Benjamin F Miller iD

Journal of Cachexia, Sarcopenia and Muscle · 2026-12 · 17 (6)

DOI: 10.1002/jcsm.70426 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Cachexia, Sarcopenia and Muscle, online erschienen am 10.11.2026. Verfasst von Colleen L O'Reilly und 6 weiteren Autor:innen. Beteiligte Einrichtung: Aging and Metabolism Research Program, Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma, USA. Hauptthemen laut MEDLINE: Proteomics, Deuterium Oxide. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIA NIH HHS, BLRD VA, Veterans Affairs.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Measuring in vivo protein synthesis is important for testing how interventions, disease and ageing remodel the proteome. A limitation of approaches using short‐term infusions of labelled amino acids was that long‐term changes had to be extrapolated from short‐term measurements. Deuterium oxide (D 2 O) is now widely used because it can measure protein synthesis over periods of days to weeks. We previously showed that the duration of labelling impacts measured protein synthesis, but many still employ repeated tissue sampling during D 2 O provision. We hypothesized that the timing of tissue sampling alters which proteins contribute to the overall protein fractional synthesis rate (FSR), thereby invalidating comparisons between serial samples collected during continuous labelling.

Methods

To test this hypothesis, we used a five‐timepoint (0d, 4d, 15d, 30d and 45d) D 2 O labelling time course followed by liquid chromatography–tandem mass spectrometry proteomics to calculate individual protein synthesis rates and plateau values in mouse gastrocnemius muscle. Individual proteins were stratified into slow and fast groups, such that each group was responsible for the slowest or fastest 20% of total synthesis over the first 4 days of labelling, respectively.

Results

In a 4‐day period representing a baseline period, the synthesis rate of summed proteins was 2.09%/day. When the period was extended to 15, 30 or 45 days, the synthesis rates of summed proteins declined to 1.64%, 1.31% and 1.10%/day, respectively. The contribution of slow and fast proteins to these rates changed as a function of time. The fast and slow proteins accounted for 4.3% and 34.0% of measured proteome abundance, respectively. From Day 0 to Day 4, fast and slow proteins contributed 19.8% and 20.2% of the calculated FSR, respectively. By Day 45, these contributions shifted to 6.5% and 28.8%. Further, we demonstrated that the assumption that the fraction new of proteins linearly increases to 100% new is not true for the majority of proteins. Instead, most proteins plateaued at some point less than 100%, which stops their individual contribution to a summed protein synthesis rate.

Conclusions

In continuous long‐term labelling studies, biopsy timing changes the measured bulk FSR because the relative contributions of individual proteins to that measurement over time. Fast proteins that plateau early decrease their contribution as labelling time increases. These findings indicate that studies with different labelling periods, or multiple biopsies over time during continuous labelling of days to weeks cannot be compared to biopsies taken at other times in the labelling period.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ProteomicsDeuterium OxideAnimalsMiceBiopsyMuscle, SkeletalMaleProteomeTime FactorsIsotope LabelingTandem Mass Spectrometry

Stichwörter der Autor:innen

biopsydeuterium oxideproteomicsskeletal musclestable isotopes

Substanzen

Deuterium OxideProteome

Autor:innen und Institutionen

  • Aging and Metabolism Research Program, Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma, USA.
  • Department of Biochemistry and Physiology, University of Oklahoma Health Campus, Oklahoma City, Oklahoma, USA.
  • Department of Biochemistry and Molecular Biology, The University of Texas Medical Branch, Galveston, Texas, USA.
  • Veterans Affairs Medical Center, Oklahoma City, Oklahoma, USA.

ORCID-Profile: Colleen L O'Reilly, Michael E Taylor, Ying Ann Chiao, Rovshan G Sadygov, Benjamin F Miller

Förderung

  • NIA NIH HHS
  • BLRD VA
  • Veterans Affairs
  • NIH HHS
  • NIGMS NIH HHS
  • U.S. Department of Veterans Affairs
  • National Institutes of Health

Zitieren

APA

O'Reilly, C. L., Taylor, M. E., Kobak, K. A., Chiao, Y. A., Sadygov, R. G., Kinter, M. T., & Miller, B. F. (2026). Deuterium‐Oxide Labelling Proteomics Illustrates the Importance of Sample Timing and the Limitations of Serial Biopsies. Journal of Cachexia, Sarcopenia and Muscle, 17(6). https://doi.org/10.1002/jcsm.70426

Vancouver

O'Reilly CL, Taylor ME, Kobak KA, Chiao YA, Sadygov RG, Kinter MT, et al. Deuterium‐Oxide Labelling Proteomics Illustrates the Importance of Sample Timing and the Limitations of Serial Biopsies. Journal of Cachexia, Sarcopenia and Muscle. 2026;17(6). doi:10.1002/jcsm.70426

BibTeX
@article{OReilly2026,
  author = {O'Reilly, Colleen L and Taylor, Michael E and Kobak, Kamil A and Chiao, Ying Ann and Sadygov, Rovshan G and Kinter, Michael T and Miller, Benjamin F},
  title = {Deuterium‐Oxide Labelling Proteomics Illustrates the Importance of Sample Timing and the Limitations of Serial Biopsies},
  journal = {Journal of Cachexia, Sarcopenia and Muscle},
  year = {2026},
  volume = {17},
  number = {6},
  doi = {10.1002/jcsm.70426}
}
Kostenlos starten →